Trial intelligence / Profile preview

Deep Neuromuscular Blockade in Laparoscopic Colorectal Surgery

NCT03890406Completed

Sponsor
Seoul National University Bundang Hospital
Start
Apr 2019
Primary completion
Dec 2019
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of rocuronium (2 arms), sponsored by Seoul National University Bundang Hospital. Primary endpoint: Dosage of propofol. Started Apr 2019; status: completed.

02

Drugs

rocuronium

Beyond the preview

Go deeper on NCT03890406.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03890406.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call